Stemtech Corporation

STEK

US85859W1027

Pharmaceuticals

Delayed OTC Markets Other stock markets 14:30:00 13/05/2024 BST			5-day change	1st Jan Change
0.058 ^USD	0.00%		-0.51%	+78.46%

01-31	Stemtech Corporation Expands Global Reach with New License Agreement in Africa	CI
2023	Stemtech Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Stemtech Corporation Announces Introduction of Cellectone Rapid Renew Stem Cell Peptide Night Cream

December 06, 2022 at 03:00 pm

Stemtech Corporation (Stemtech) announced the introduction of their new CellectOne™ innovative and cutting-edge Skincare line, with the first product being the Rapid Renew Stem Cell Peptide Night Cream.

Latest news about Stemtech Corporation

Stemtech Corporation Expands Global Reach with New License Agreement in Africa	01-31	CI
Stemtech Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	12-01	CI
Stemtech Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	22/08/23	CI
Stemtech Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Stemtech Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	11/05/23	CI
Stemtech Corporation Auditor Raises 'Going Concern' Doubt	10/05/23	CI
Stemtech Corporation completed the acquisition of Life Factor Research for $7.9 million.	30/03/23	CI
Stemtech Corporation announced that it expects to receive $6.16 million in funding from Leviston Resources LLC	26/03/23	CI
Stemtech Corporation Announces Additional Expansion of International Markets	02/02/23	CI
Stemtech Corporation Appoints Margie and Mike Mares to Field Advisory Board	10/01/23	CI
Stemtech Cororation Announces Life Factor Research Obtains First Production Contract with New Customer	22/12/22	CI
Stemtech Corporation Announces Introduction of Cellectone Rapid Renew Stem Cell Peptide Night Cream	06/12/22	CI
Stemtech Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	23/11/22	CI
Stemtech Corporation Announces Creation of New Stem Cell Skincare Products	19/09/22	CI
Stemtech Corporation Announces Professor Dr. Bankole Johnson Joins Their Life Sciences Advisory Board	06/09/22	CI
Stemtech Corporation entered into a letter of intent to acquire Life Factor Research.	28/08/22	CI
Stemtech Corporation Announces Orastem Trademark Registration in Mexico and Introduces New Travel Size	23/08/22	CI
Stemtech Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	23/08/22	CI
Globe Net Wireless Corp. has Changed its Ticker to STEK from GNTW	14/04/22	CI
Globe Net Wireless Corp has Changed its Name to STEMTECH CORPORATION	14/04/22	CI
Globe Net Wireless Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	01/04/22	CI
Globe Net Wireless Corp. Auditor Raises 'Going Concern' Doubt	31/03/22	CI
Globe Net Wireless Corp. Changes Year End	12/11/21	CI
Stemtech Corporation Announces Appointment of John W. Meyer to Role of President and COO	19/10/21	CI
Stemtech Corporation Announces Appointment of Two Additional Board Members	06/10/21	CI

Chart Stemtech Corporation

Duration

Period

More charts

Company Profile

Stemtech Corporation is a global network marketing company that develops science-based products, which support wellness by helping the body maintain healthy stem cell physiology, also known as stem cell enhancers. The Company is also known as Stem Cell Nutrition Company. The Company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood and migrate them into tissues, where they can perform their daily function of renewal for optimal health. These products are marketed internationally by the Companies subsidiaries and through independent distributors. The Company markets its products under various brands, which include RCM System, stemrelease3, Stemflo MigraStem, OraStem (Oral Health Care), and D-Fuze (Electromagnetic Frequency blocker). It also introduced a skincare product, Cellect One Rapid Renew Stem Cell Peptide Night Cream. Its segments include North America, Latin America and Asia.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Biopharmaceuticals

	1st Jan change	Capi.
STEMTECH CORPORATION	+78.46%	6.77M
CSL LIMITED	-2.35%	89.08B
SAMSUNG BIOLOGICS CO.,LTD.	+3.55%	40.9B
BIOGEN INC.	-13.54%	32.25B
UCB	+53.87%	25.14B
BIOMARIN PHARMACEUTICAL INC.	-15.92%	15.39B
INCYTE CORPORATION	-7.37%	11.91B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-41.29%	11.89B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-11.75%	11.64B
SWEDISH ORPHAN BIOVITRUM AB	+6.82%	9.03B